Study guide

6.3 Systemic, Neuraxial & Regional Analgesia in Labor

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

6.3 Systemic, Neuraxial & Regional Analgesia in Labor

Key Takeaways Explain This Topic AI

Nitrous oxide must be self-administered by the patient holding her own mask; a support person or clinician must never hold the mask for her.

Butorphanol and nalbuphine are mixed agonist-antagonists that precipitate immediate severe withdrawal in patients on methadone or buprenorphine and are absolutely contraindicated in opioid dependence.

Parenteral opioids given within 1 to 2 hours of birth peak in the fetus at cord clamping, and naloxone is not part of delivery-room resuscitation and is contraindicated in neonates of opioid-dependent mothers.

Neuraxial analgesia generally requires a platelet count of 70,000 to 100,000 per microliter or higher with normal coagulation to avoid epidural hematoma.

Post-dural puncture headache is worse upright and relieved supine, and an autologous epidural blood patch of 15 to 20 mL relieves more than 90 percent of refractory cases.

Last updated: September 2026

  • Systemic Pharmacologic Analgesia
  • 1. Inhaled Nitrous Oxide

Nitrous oxide is an inhaled analgesic gas administered as a fixed, premixed formulation of 50% nitrous oxide (N2O) and 50% oxygen (O2) .

Mechanism of Action: Stimulates endogenous opioid release, activates GABA-A receptors, and inhibits NMDA receptors in the central nervous system, creating analgesia, mild euphoria, and dissociation without motor blockade.

Administration Technique: Strictly client-controlled and self-administered . The laboring woman holds a handheld mask equipped with a one-way demand valve and a gas scavenger system. She begins inhaling deeply approximately 30 seconds prior to an anticipated contraction , ensuring peak drug absorption aligns with the peak intensity of the contraction.

Pharmacokinetics: Rapid alveolar uptake with onset of action within 30 to 50 seconds; rapid pulmonary clearance within minutes of mask removal.

Safety & Benefits: Does not depress myometrial contractility, does not alter baseline FHR or variability, and does not cause neonatal respiratory depression. The woman retains protective airway reflexes and full mobility.

Contraindications: Inability of the patient to hold the mask independently (a support person or clinician must never hold the mask), hemodynamic instability, impaired consciousness, acute alcohol or sedative intoxication, severe pneumothorax, bowel obstruction, middle ear surgery, or known vitamin B12 deficiency.

2. Systemic Intravenous Opioids

Medication Class & Dosage Onset & Duration Clinical Pearls & Critical Precautions

Fentanyl (Sublimaze) Pure synthetic mu-agonist; 50 to 100 mcg IV q1–2h Onset: 2–3 min; Duration: 30–60 min Rapid onset and short duration make it ideal for late active labor. Minimal active metabolites; lowest rate of delayed neonatal depression.

Butorphanol (Stadol) Mixed agonist-antagonist; (kappa-agonist, mu-antagonist); 1 to 2 mg IV q3–4h Onset: 5–10 min; Duration: 3–4 hours Features a ceiling effect on respiratory depression . Can produce a transient, benign pseudo-sinusoidal FHR pattern. Strictly contraindicated in opioid dependence.

Nalbuphine (Nubain) Mixed agonist-antagonist; (kappa-agonist, mu-antagonist); 10 mg IV q3–6h Onset: 5–10 min; Duration: 3–6 hours Features ceiling effect on respiratory depression; causes less nausea than morphine. Strictly contraindicated in opioid dependence.

Morphine Sulfate Pure natural mu-agonist; 5 to 10 mg IM/IV Onset: 15–20 min; Duration: 4–5 hours Primarily reserved for therapeutic rest in prolonged latent phase . Avoid in active labor near delivery due to prolonged active metabolites (M6G).

Critical Safety Rules for Parenteral Opioids

Ceiling Effect of Mixed Agonist-Antagonists: Butorphanol and nalbuphine exhibit a ceiling effect, meaning higher doses do not cause progressive respiratory depression; however, they also exhibit a ceiling on analgesic efficacy.

The Opioid-Dependent Absolute Contraindication: Administering butorphanol or nalbuphine to an individual with opioid use disorder or someone maintained on methadone or buprenorphine is strictly contraindicated . Because these agents possess high-affinity partial mu-antagonist activity, they will rapidly displace pure mu-agonists from central receptors, precipitating immediate, severe acute opioid withdrawal (acute maternal hypertension, tachycardia, violent diaphoresis, severe abdominal cramping, and acute fetal distress).

Timing Relative to Delivery: Maternal IV opioids cross the placenta via passive diffusion. If administered within 1 to 2 hours of birth , fetal drug levels peak just as the umbilical cord is clamped, leading to neonatal respiratory depression, decreased muscle tone, impaired suckling, and hypothermia.

Neonatal Resuscitation & Naloxone Caution: In the event of opioid-induced neonatal respiratory depression, the primary intervention per Neonatal Resuscitation Program (NRP) guidelines is effective positive-pressure ventilation (PPV) and airway management . Naloxone (Narcan) is not recommended as part of initial delivery room resuscitation, and is strictly contraindicated in neonates born to opioid-dependent individuals , as it can trigger life-threatening neonatal seizures and acute cardiopulmonary collapse.

Neuraxial Analgesia: Epidural, CSE & Spinal

Neuraxial techniques provide the most effective pain relief available in modern obstetrics:

Epidural Analgesia: Continuous infusion or Patient-Controlled Epidural Analgesia (PCEA) of a dilute local anesthetic (e.g., bupivacaine 0.0625%–0.125% or ropivacaine ) combined with a lipid-soluble opioid (e.g., fentanyl 2 mcg/mL ) into the lumbar epidural space (typically at L2–L3 or L3–L4).

Combined Spinal-Epidural (CSE): Combines an immediate intrathecal "single-shot" injection of a low-dose local anesthetic and opioid into the subarachnoid space (providing instant, dense pain relief within 2 to 5 minutes) with the placement of an indwelling epidural catheter for ongoing maintenance.

Pre-Procedure Evaluation:

Platelet Count: Platelets must be verified. While individual clinical scenarios vary, a platelet count ≥ 70,000 to 100,000/μL with normal coagulation parameters is generally required to avoid the catastrophic risk of an epidural hematoma causing spinal cord compression.

Intravascular Pre-Hydration: Administer a rapid crystalloid infusion of 500 to 1,000 mL Lactated Ringer's to expand intravascular volume.

Procedural Side Effects & Complications

Complication Underlying Mechanism Clinical Manifestation & Management

Maternal Hypotension Sympathetic nerve blockade causes arterial vasodilation and venous pooling Blood pressure drops ≥ 20%; nausea/dizziness; fetal bradycardia. Tx: Lateral tilt, rapid IV fluid bolus, ephedrine (5–10 mg IV) or phenylephrine (50–100 mcg IV) .

Pruritus Neuraxial opioid stimulation of mu-receptors in the spinal dorsal horn and medullary itch center Intense itching of face, neck, and thorax. Tx: Low-dose naloxone infusion (0.25–1 mcg/kg/hr), diphenhydramine, or ondansetron.

Maternal Pyrexia Non-infectious thermoregulatory disruption and cytokine release Elevated temperature (>38.0°C); requires careful differential diagnosis to exclude chorioamnionitis.

Urinary Retention Sensory and motor blockade of the S2–S4 parasympathetic bladder innervations Bladder distension obstructing fetal descent. Tx: Scheduled straight catheterization every 2 to 3 hours.

Post-Dural Puncture Headache (PDPH) Accidental puncture of the dura mater ("wet tap") causes continuous leakage of CSF Severe frontal/occipital headache; worse upright, relieved completely supine . Tx: Hydration, caffeine, and epidural blood patch .

Exam Watchout — Epidural Blood Patch: The definitive gold-standard treatment for persistent, severe post-dural puncture headache (PDPH) failing conservative therapy is an autologous epidural blood patch . Under sterile technique, 15 to 20 mL of the patient's own venous blood is drawn and injected directly into the epidural space at or adjacent to the prior dural puncture site. The coagulating blood forms a mechanical gelatinous plug that halts further CSF leakage, providing immediate relief in >90% of cases.

  • Local & Regional Nerve Blocks
  • 1. Pudendal Nerve Block

The pudendal block is a highly effective regional nerve block utilized during late second stage, operative vaginal delivery (vacuum or forceps), or extensive perineal and vaginal laceration repair (third- or fourth-degree lacerations).

Neuroanatomy: The pudendal nerve originates from the ventral rami of the second, third, and fourth sacral nerves ( S2, S3, S4 ). It exits the pelvis through the greater sciatic foramen, crosses behind the ischial spine and sacrospinous ligament , and re-enters the pelvis through the lesser sciatic notch, traveling along the lateral wall of the ischiorectal fossa within Alcock's canal .

Sensory Distribution: Provides dense somatic sensory anesthesia to the lower vagina, labia majora and minora, perineal body, and perianal region. Importantly, it does not eliminate uterine contraction pain (T10–L1) and does not cause motor blockade of maternal abdominal pushing muscles .

Anatomical Landmarks & Technique:

The CNM palpates the maternal ischial spine and the adjacent sacrospinous ligament transvaginally with the index and middle fingers.

A specialized needle guide (the Iowa trumpet ) is positioned through the vagina directly against the sacrospinous ligament, approximately 1 cm medial and posterior to the ischial spine tip.

A long 20- or 22-gauge needle is advanced through the guide, piercing the sacrospinous ligament until a subtle "pop" or loss of resistance is felt.

Mandatory Aspiration: The clinician must aspirate vigorously prior to injection to ensure the needle tip has not entered the internal pudendal artery or vein , which run immediately adjacent to the nerve.

Inject 5 to 10 mL of 1% lidocaine (or 2-chloroprocaine) without epinephrine into the space behind the ligament. The procedure is repeated on the contralateral side for a bilateral block.

2. Local Perineal Infiltration

Direct infiltration of local anesthetic into the tissues of the posterior fourchette and perineal body prior to performing an indicated episiotomy or repairing first- and second-degree perineal lacerations.

Agent: 1% or 2% lidocaine without epinephrine (maximum safe dose: 4.5 mg/kg or up to 300 mg, equivalent to 30 mL of 1% lidocaine).

Technique: Insert the needle into the apex of the mucosal tear or fourchette, aspirate to rule out intravascular placement, and inject a fan-shaped field while slowly withdrawing the needle.

Loading diagram... Clinical Spectrum of Intrapartum Pain Management Modalities